Back to search

Article

Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: A trial design

2020-01-28

Abstract excerpt

<title>Abstract</title> <p>Background: The symptom severity of a substantial group of schizophrenia patients (30-40%) does not improve through pharmacotherapy with antipsychotic medication, indicating a clear need for new treatment options to improve schizophrenia outcome. Meta-analyses, genetic studies, randomized controlled trials and post-mortem studies suggest that immune dysregulation plays a role in the pat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4efdfb6d-295a-567e-a0ec-e72527c0a5d7
DOI
10.21203/rs.2.9925/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: A trial designDOI 10.21203/rs.2.9925/v2
Prednisolone Versus Colchicine for Acute Gout in Primary Care (COPAGO). Protocol for a two-arm multicentre, pragmatic, prospective, randomised, double-blind, controlled clinical trial of prednisolone and colchicine for non-inferiority with a parallel group design.Semantic proximity
Prednisolone Versus Colchicine for Acute Gout in Primary Care: statistical analysis plan for the pragmatic, multicenter, randomized, and double-blinded COPAGO non-inferiority trialSemantic proximity
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia.Semantic proximity
The association of change in serum cholesterol levels and clinical treatment response in patients with schizophrenia: a prospective, randomized and open-label studySemantic proximity
Altered levels of cytokine, T- and B-lymphocytes, and PD-1 expression rates in drug- naïve schizophrenia patients with acute phaseSemantic proximity
MicroRNAs and pro-inflammatory cytokines as candidate biomarkers for recent-onset psychosisSemantic proximity
Association between PLA2 gene polymorphisms and treatment response to antipsychotic medications: A study of antipsychotic-naïve first-episode psychosis patients and nonadherent chronic psychosis patients.Semantic proximity
Associations of Systemic Inflammation and Senescent Cell Biomarkers with Clinical Outcomes in Older Adults with SchizophreniaSemantic proximity
Antipsychotic drugs increase Neuregulin1b1 serum levels in first-episode drug-naïve patients and chronic schizophrenia with suggestions for improving the treatment of psychotic symptomsSemantic proximity
Effects of Antipsychotics on the Inflammatory Response System of Patients with Schizophrenia in Peripheral Blood Mononuclear Cell CulturesSemantic proximity
eNACT: A protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first episode psychosisSemantic proximity
Association between elevated serum matrix metalloproteinase-2 and tumor necrosis factor-α, and clinical symptoms in male patients with treatment-resistant and chronic medicated schizophreniaSemantic proximity
Select a neighboring publication to make it the new centre.